AU2002314040B2 - Self-containing lactococcus strain - Google Patents

Self-containing lactococcus strain Download PDF

Info

Publication number
AU2002314040B2
AU2002314040B2 AU2002314040A AU2002314040A AU2002314040B2 AU 2002314040 B2 AU2002314040 B2 AU 2002314040B2 AU 2002314040 A AU2002314040 A AU 2002314040A AU 2002314040 A AU2002314040 A AU 2002314040A AU 2002314040 B2 AU2002314040 B2 AU 2002314040B2
Authority
AU
Australia
Prior art keywords
lactococcus
gene
strain
thya
lactis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002314040A
Other languages
English (en)
Other versions
AU2002314040A1 (en
Inventor
Lothar Steidler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intrexon Actobiotics NV
Original Assignee
Intrexon Actobiotics NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intrexon Actobiotics NV filed Critical Intrexon Actobiotics NV
Publication of AU2002314040A1 publication Critical patent/AU2002314040A1/en
Assigned to ACTOGENIX N.V. reassignment ACTOGENIX N.V. Request for Assignment Assignors: VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW
Application granted granted Critical
Publication of AU2002314040B2 publication Critical patent/AU2002314040B2/en
Assigned to INTREXON ACTOBIOTICS NV reassignment INTREXON ACTOBIOTICS NV Request to Amend Deed and Register Assignors: ACTOGENIX N.V.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y201/00—Transferases transferring one-carbon groups (2.1)
    • C12Y201/01—Methyltransferases (2.1.1)
    • C12Y201/01045—Thymidylate synthase (2.1.1.45)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
AU2002314040A 2001-05-03 2002-05-03 Self-containing lactococcus strain Ceased AU2002314040B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP01201631.7 2001-05-03
EP01201631 2001-05-03
EP01204785.8 2001-12-07
EP01204785 2001-12-07
PCT/EP2002/004942 WO2002090551A2 (en) 2001-05-03 2002-05-03 Self-containing lactococcus strain

Publications (2)

Publication Number Publication Date
AU2002314040A1 AU2002314040A1 (en) 2003-05-01
AU2002314040B2 true AU2002314040B2 (en) 2007-06-28

Family

ID=26076897

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002314040A Ceased AU2002314040B2 (en) 2001-05-03 2002-05-03 Self-containing lactococcus strain

Country Status (9)

Country Link
EP (1) EP1383897B1 (enExample)
JP (2) JP4347575B2 (enExample)
AT (1) ATE331789T1 (enExample)
AU (1) AU2002314040B2 (enExample)
CA (1) CA2446776C (enExample)
DE (1) DE60212825T2 (enExample)
DK (1) DK1383897T3 (enExample)
ES (1) ES2266515T3 (enExample)
WO (1) WO2002090551A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
DE60319822T2 (de) 2002-06-19 2009-06-04 Actogenix Nv Verfahren und mittel zur erhöhung der darmabsorption
WO2004056850A2 (en) * 2002-12-19 2004-07-08 Vib Vzw Mutant proteins showing increased secretion
JP4589618B2 (ja) * 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
WO2006018446A2 (en) * 2004-08-20 2006-02-23 Actogenix Nv Method to improve lactococcus preservation
DK2119450T3 (da) * 2005-11-29 2013-05-06 Actogenix Nv Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
CA2672229A1 (en) * 2006-12-14 2008-06-19 Actogenix N.V. Delivery of binding molecules to induce immunomodulation
CN101605900B (zh) * 2007-01-12 2014-04-23 阿克图杰尼斯公司 乳球菌启动子和其用途
BRPI0807857A2 (pt) 2007-01-25 2014-05-27 Actogenix Nv Tratamento de doença imune por meio de distribuição através da mucosa de antígenos.
JP2012504116A (ja) * 2008-09-29 2012-02-16 アクトジェニックス・エヌブイ 粘膜での微生物のコロニー形成の低減
EP2714912B1 (en) 2011-06-01 2018-05-02 Intrexon Actobiotics NV Polycistronic expression system for bacteria
HUE038830T2 (hu) 2011-09-23 2018-11-28 Intrexon Actobiotics Nv Módosított gram-pozitív baktériumok és alkalmazásaik
CN103917639B (zh) 2011-09-23 2017-09-26 英特瑞克斯顿阿克图比奥帝克斯有限公司 经修饰的革兰氏阳性细菌及其用途
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
KR20170121291A (ko) * 2015-03-02 2017-11-01 신로직 인코포레이티드 감소된 창자 염증 및/또는 강화된 창자 점막 장벽으로부터 이익을 얻는 질병을 치료하기 위해 공학처리된 박테리아
CN106148254B (zh) * 2015-03-26 2019-11-12 南京华贞生物医药科技有限公司 一种用于减肥降脂的转化体及其构建方法与应用
EP3882259B1 (en) 2015-05-13 2026-01-28 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
JP6993970B2 (ja) 2015-11-16 2022-02-15 シンロジック オペレーティング カンパニー インコーポレイテッド 高フェニルアラニン血症を低減させるように操作された細菌
JP7292877B2 (ja) 2016-01-14 2023-06-19 イントレクソン・アクトバイオテイクス・エヌブイ １型糖尿病を処置するための組成物および方法
US10858663B2 (en) 2016-09-02 2020-12-08 Intrexon Actobiotics N.V. Genetically modified bacteria stably expressing IL-10 and insulin
KR102469701B1 (ko) 2016-09-13 2022-11-22 인트랙슨 액토바이오틱스 엔.브이. 점막부착성 미생물
EP3642221A1 (en) 2017-06-21 2020-04-29 Synlogic Operating Company, Inc. Bacteria for the treatment of disorders
EP3864048A1 (en) 2018-10-11 2021-08-18 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Bacteria expressing single chain antibodies against toll-like receptors
CA3156035A1 (en) 2019-09-27 2021-04-01 Intrexon Actobiotics Nv D/B/A Precigen Actobio Treatment of celiac disease
WO2021188819A1 (en) 2020-03-20 2021-09-23 Synlogic Operating Company, Inc. Microorganisms engineered to reduce hyperphenylalaninemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4231764A1 (de) * 1992-09-23 1994-03-24 Inst Pflanzengenetik & Kultur Verfahren zur chromosomalen Integration eines Produkt-Gens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ross et al., 1990, Applied and Environmental Microbiology (56) p2164-2169. *

Also Published As

Publication number Publication date
DK1383897T3 (da) 2006-10-30
JP2004533246A (ja) 2004-11-04
ATE331789T1 (de) 2006-07-15
JP4347575B2 (ja) 2009-10-21
CA2446776A1 (en) 2002-11-14
DE60212825T2 (de) 2007-01-11
ES2266515T3 (es) 2007-03-01
DE60212825D1 (de) 2006-08-10
EP1383897A2 (en) 2004-01-28
CA2446776C (en) 2011-07-12
JP2009060913A (ja) 2009-03-26
WO2002090551A2 (en) 2002-11-14
EP1383897B1 (en) 2006-06-28
WO2002090551A3 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
EP1383897B1 (en) Self-containing lactococcus strain
US20100316611A1 (en) Self-containing lactococcus strain
AU2002314040A1 (en) Self-containing lactococcus strain
US20050276788A1 (en) Self-containing lactobacillus strain
CA2738781C (en) Reduced colonization of microbes at the mucosa
US8759088B2 (en) Lactococcus promoters and uses thereof
AU2013327059B2 (en) Immunomodulatory minicells and methods of use
CA2342040C (en) Anaerobic bacterium as a drug for cancer gene therapy
US20080253990A1 (en) Self-Containing Lactobacillus Strain
JPH09512030A (ja) 選択マーカー遺伝子のない ｄｎａベクターを用いる遺伝子治療方法
WO2022007741A1 (en) Genetically engineered live bacteria and methods of constructing the same
KR20040072545A (ko) 비피도박테리움 롱검 ｍｇ1 유래 신규 플라스미드를함유하는 셔틀벡터
HK1227928A1 (en) Lactococcus promoters and uses thereof

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ACTOGENIX N.V.

Free format text: FORMER APPLICANT(S): VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 03 MAY 2008 TO 03 DEC 2008 IN WHICH TO PAY A RENEWAL FEE HAS BEEN FILED .

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A RENEWAL FEE HAS BEEN EXTENDED TO 03 DEC 2008.

HB Alteration of name in register

Owner name: INTREXON ACTOBIOTICS NV

Free format text: FORMER NAME(S): ACTOGENIX N.V.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired